Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$57,736,777
+$57,161,648 QoQ
Shares Held
502,846
+5600.6% QoQ
Ownership
0.860%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Derivatives in ACLX
reported options exposure · as of Mar 31, 2025CallValue
$675,680
CallShares
10,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. ACLX ranks #13 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ACLX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,736,777 | 502,846 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $575,129 | 8,821 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,311,996 | 40,341 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,226,907 | 94,562 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $675,680 | 10,300 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $3,349,273 | 51,056 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,715,555 | 22,370 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $835,100 | 10,000 | Call | Sole | 2024-11-14 | |
| 2024-03-31 | $4,257,155 | 61,210 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,184,257 | 57,374 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $358,800 | 10,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $1,842,976 | 51,365 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,656,308 | 242,135 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,721,786 | 120,798 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,177,181 | 70,277 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $398,637 | 21,238 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,545,858 | 85,501 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,278,834 | 91,215 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||